1. Home
  2. INLX vs CVM Comparison

INLX vs CVM Comparison

Compare INLX & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intellinetics Inc.

INLX

Intellinetics Inc.

HOLD

Current Price

$8.18

Market Cap

36.5M

Sector

Technology

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$4.90

Market Cap

41.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INLX
CVM
Founded
1996
1983
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.5M
41.2M
IPO Year
N/A
1987

Fundamental Metrics

Financial Performance
Metric
INLX
CVM
Price
$8.18
$4.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.2K
75.7K
Earning Date
03-23-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,539,674.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.50
$1.98
52 Week High
$15.72
$20.41

Technical Indicators

Market Signals
Indicator
INLX
CVM
Relative Strength Index (RSI) 50.69 41.61
Support Level $8.00 $4.60
Resistance Level $8.51 $5.20
Average True Range (ATR) 0.09 0.50
MACD 0.02 -0.07
Stochastic Oscillator 45.90 8.20

Price Performance

Historical Comparison
INLX
CVM

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: